Page results
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
UCLH treats a range of red cell blood disorders and anaemias.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
File results
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0420 - Commercialisation of NHS patient data